Skip to main content

Recent News

Nice overview of what our colleagues are upto at the gout education society - Drs. Jas Singh, Hyun Choi and Tuhina Neogi!! https://t.co/9v2m0EcvhT https://t.co/3iYv0WlcL9

Dr. John Cush @RheumNow (  View Tweet)

Sep 25, 2020
High-risk coronary plaques (LRNC) assessed by Coronary CT scores in 209 biologic naive Psoriasis pts. LNRC correlated w/ Framingham risk & Dz activity.

Dr. John Cush @RheumNow (  View Tweet)

Sep 25, 2020

EULAR Updated 2019 Recommendations for Psoriatic Arthritis Mnagement

Sep 24, 2020

In June 2020, we failed to report on the ARD publication updating the 2019 update the European League Against Rheumatism (EULAR) recommendations for the pharmacological treatment of psoriatic arthritis (PsA) - these are presented below.

Read Article

Romilkimab Effective in Early Diffuse Systemic Sclerosis

Sep 24, 2020

A phase II study of patients with early diffuse systemic sclerosis (SSc) has demonstrated improvement in SSc skin outcomes by targeting T cells and fibrosis with the bispecific monoclonal antibody romilkimab (RMK).

Romilkimab is an engineered, humanised, bispecific immunoglobulin-G4 antibody that binds and neutralises IL-4/IL-13 making it ideal for exploration in fibrosis. 

Read Article
Rheums Win Big in 2021! According to the estimates from the Centers for Medicare & Medicaid Services (CMS), endocrinologists and rheumatologists are the big winners, at 17% and 16% projected increases, respectively https://t.co/I6etQZnFlv

Dr. John Cush @RheumNow (  View Tweet)

Sep 24, 2020
Swedish GWAS study of >850,000 individuals shows Genetically predicted BMI (obesity) significantly increases RA riskk, but no correlation of RA risk to waist-to-hip ratios. https://t.co/YkzwjPOVyE

Dr. John Cush @RheumNow (  View Tweet)

Sep 24, 2020
FDA has issued a new guidance document outlining the inclusion of geriatric information in drug labeling detect; especially noting geriatic studies and when efficacy and safety differs from that seen in younger adults https://t.co/jTLDae3Gff

Dr. John Cush @RheumNow (  View Tweet)

Sep 24, 2020

Ustekinumab Early Risk for Cardiovascular Events

Sep 23, 2020

JAMA Dermatology reports a claims-based, case-time-controlled French study of 9290 psoriasis patients suggesting that ustekinumab initiation may be associated with an increased risk of acute coronary syndrome or stroke in high risk cardiovascular patients.

Read Article

Young Adults are Driving Up COVID-19 Rates

CDC/MMWR
Sep 23, 2020

CDC reports that since June 2020 individuals infected with COVID-19 have largely been young adults in the 20-29 year age bracket. Moreover, younger adults appeared to be driving community transmission of COVID-19. 

Read Article

Livedo, Purpura and Coagulopathy in Severe COVID-19

Sep 23, 2020

JAMA Dermatology expands the spectrum of complications seen with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection describing cutaneous purpura and livedo lesions in patients with severe COVID-19.

A flurry of recent reports have described livedoid and necrotic eruptions in confirmed COVID-19 cases many of whom had severe disease.

Read Article
The EMAs Committee for Medicinal Products for Human Use (CHMP) has recommended baricitinib for approval in adults with moderate-to-severe atopic dermatitis who are candidates for systemic therapy https://t.co/goEacN1C8X

Dr. John Cush @RheumNow (  View Tweet)

Sep 23, 2020
Global task force establishes protocols for medical cannabis use to treat pain. Start low (5mg CBD) and titrate up (max 40 mg) - ALL Expert opinion, no good evidence (largely bunk?) https://t.co/HyYU0tGVF5

Dr. John Cush @RheumNow (  View Tweet)

Sep 23, 2020
Cluster analysis of 168 antiphospholipid pts shows that having arterial thromboses and cardiovascular risk factors was associated with mortality and poorest prognosis in APS. https://t.co/Nb7lZNu4jT

Dr. John Cush @RheumNow (  View Tweet)

Sep 23, 2020

CDC Reverses Guidance for Asymptomatic COVID Contacts

Sep 22, 2020

Asymptomatic people who have been exposed to COVID-19 should be tested, the CDC said on Friday, in a reversal of controversial guidance the agency introduced in late August.

It is now unequivocal, with the agency stating that for individuals without symptoms who have been in close contact with an infected person for at least 15 minutes: "You need a test."

Read Article
Pain in Knee Osteoarthritis comes from what?

Dr. John Cush @RheumNow (  View Tweet)

Sep 22, 2020
Questions or Comments to Cush for the RheumNow Podcast? Weigh in with "Back Talk" wherein Ill discuss your question, query and theory https://t.co/Ngg7XyS6ns https://t.co/DuQHfGnXWO
Dr. John Cush @RheumNow (  View Tweet)
Sep 22, 2020
Ann Int Med shows again that steroids increase serious infection risk in a dose dependenet manner, but even 5 mg of prednisone or less also gives a small but significant risk of serious infection in RA patients on DMARDs (claims data from Medicare & Optum) https

Dr. John Cush @RheumNow (  View Tweet)

Sep 22, 2020
A machine-learning algorithm was developed using MRI data from the Osteoarthritis Initiative capable of predicting osteoarthritic progressors from baseline cartilage texture maps ; Had a test accuracy of 78% in detecting OA progression 3 y prior to Sxs https://t.co

Dr. John Cush @RheumNow (  View Tweet)

Sep 22, 2020
Outcomes survey of 229 relapsing polychondritis patients shows that 59% had auricular-onset (AO) and 21% had respiratory -onset (RO), 20% w/ miscellaneous-onset (MO- eye MSK CNS).

Dr. John Cush @RheumNow (  View Tweet)

Sep 22, 2020
6.6% Risk of Late-onset Neutropenia (ANC<1000) in a single center study of 738 Rx w/ Rituximab (107 LON in 71 patients). Incidence was 7.2/100PYs. Higher risk w/ SLE or CTX Rx. 40% had Sxs, Fever 31%, sepsis in 8.5%.

Dr. John Cush @RheumNow (  View Tweet)

Sep 21, 2020
×